Abbott Point of Care

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Abbott Point of Care sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 2 currently recruiting 5 completed upper quartile by trial count

Abbott Point of Care: 8 sponsored US clinical trials, 2 recruiting.

Abbott Point of Care sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Hematologic Tests, with 2 trials.

Upper-quartile sponsor footprint

Abbott Point of Care sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Abbott Point of Care pipeline

2 recruiting of 8 indexed (25% open); 5 completed (63%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hematologic Tests (2 trials), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Abbott Point of Care: open-pipeline peers nationwide

Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Abbott Point of Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%10%20%30%40% Total trials Recruiting share Abbott Point of CareAB ScienceAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Aciex TherapeuticsAbdul Latif Jameel Poverty Action LabAccutar BiotechnologyAdrienne G. WaksAdvocate Hospital System
Abbott Point of Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott Point of Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

What to do with this Abbott Point of Care page

8 registered trials is a research-attention snapshot, not an endorsement of Abbott Point of Care or any single study.

  • 2 of Abbott Point of Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hematologic Tests is the condition Abbott Point of Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hematologic Tests trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Abbott Point of Care pipeline card: 8 registered trials from official public datasets.Report a data error.